Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients: Implications for the differential diagnosis between MGUS and multiple myeloma

American Journal of Pathology

Volumn 152, Issue 6, 1998, Pages 1655-1665

  Ocqueteau, Mauricio ^a   Orfao, Alberto ^b   Almeida, Julia ^a   Bladé, Joan ^c   González, Marcos ^a   García Sanz, Ramón ^a   López Berges, Consuelo ^a   Moro, María J ^d   Hernández, José ^e   Escribano, Luis ^f   Caballero, Dolores ^a   Rozman, María ^c   San Miguel, Jesús F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Hospital Virgen Blanca   (Spain)

^e HOSPITAL GENERAL DE SEGOVIA   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL CLONE; CELL SUBPOPULATION; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LIGHT SCATTERING; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; ANTIGENS, CD; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PLASMA CELLS; POLYMERASE CHAIN REACTION;

EID: 0031778022     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aguzzi F, Bergami MR, Gasparro C, Belloti V, Merlini G: Occurrence of monoclonal components in general practice: clinical implications. Eur J Haematol 1992, 48:192-195
2. Ahsmann EJM, Lokhorst HM, Dekker AW, Bloem AC: Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood 1992, 79:2068-2075
3. Kyle RA: Monoclonal gammopathy of undetermined significance. Bailliere's Clin Haematol 1995, 8:761-781
4. Kyle RA: "Benign" monoclonal gammopathy: after 20 to 35 years of follow-up. Mayo Clin Proc 1993, 68:26-36
5. Kyle RA: Monoclonal gammopathy of undetermined significance and solitary plasmacytoma: implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am Multiple Myeloma 1997, 11:71-87
6. Bladé J, López-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, Vivens-Corrons JL, Montserrat E: Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992, 81:391-394
7. Ruiz-Arguelles GJ, San Miguel JF: Cell surface markers in multiple myeloma. Mayo Clin Proc 1994, 69:684-690
8. Drach J, Gattringer C, Huber H: Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol 1991, 83:418-422
9. Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M: Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood 1994, 84:2597-2603
10. Pellat-Deceunynck C, Barille S, Puthier D, Rapp MJ, Harousseau JL, Bataille R, Amiot M: Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res 1995, 55:3647-3653
11. San Miguel JF, García-Sanz R, González M, Orfao A: Immunophenotype and DNA cell content in multiple myeloma. Bailliere's Clin Haematol 1995, 8:735-759
12. Harada Y, Kawano MM, Huang N, Mahmoud MS, Lisukov IA, Mihara K, Tsujimoto T, Kuramoto A: Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996, 92:184-191
13. Van Zaanen HC, Vet RJ, de Jong CM, von dem Borne AE, van Oers MH: A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flow cytometry. Br J Haematol 1995, 91:55-59
14. Zandecki M, Facon T, Bernardi F, Izydorczyk V, Dupond L, Francois M, Reade R, Iaru T, Bauters F, Cosson A: CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance. J Clin Pathol 1995, 48:548-552
15. Sonneveld P, Durie BG, Lokhorst HM, Frutiger Y, Schoester M, Vela EE: Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma. Br J Haematol 1993, 83:63-67
16. Barker HF, Hamilton MS, Ball J, Drew M, Franklin IM: Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Br J Haematol 1992, 81:331-335
17. + is the common phenotype of myeloma cells. Ann Hematol 1992, 64:132-139
18. Chronic Leukemia-Myeloma Task Force, National Cancer Institute: Proposed guidelines for protocol studies. II. Plasma cell myeloma. Cancer Chemother Rep 1973, 4:145-158
19. Orfão A, García-Sanz R, López-Berges MC, Vidriales B, González M, Caballero MD, San Miguel JF: A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/ propidium iodide double staining technique. Cytometry 1994, 17: 332-339
20. Goodeve AC, Tagariello G, Chuansumrit A, Preston FE, Peake IR: A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII gene. Blood Coagul Fibrinolysis 1996, 7:672-677
21. Linke B, Bolz C, Hiddenmann W, Kneba M: Use of UlTma polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions. Leukemia 1995, 9:2133-2137
22. Bottaro M, Berti E, Biondi A, Migone N, Crosti L: Hetero duplex analysis of T-cell receptor g gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994, 83:3271-3278
23. Fend F, Weyrer K, Drach J, Schwaiger A, Umlauft F, Grunewald K: Immunoglobulin gene rearrangement in plasma cell dyscrasias: detection of small clonal cell populations in peripheral blood and bone marrow. Leuk Lymphoma 1993, 10:223-229
24. Corradini P, Ladetto M, Inghirami G, Boccadoro M, Pileri A: N- and K-ras oncogenes in plasma cell dyscrasias. Leuk Lymphoma 1994, 15:17-20
25. Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE: Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 1996, 88:289-296
26. Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A: Phenotypic difference of normal plasma cells from mature myeloma Cells. Blood 1993, 81: 2658-2663
27. Kawano MM, Mihara K, Tsujimoto T, Huang N, Kuramoto A: A new phenotypic classification of bone marrow plasmacytosis. Int J Hematol 1995, 61:179-188
28. Van Camp B, Durie G, Spier C, De Waele M, Van Riet I, Vela E, Frutiger Y, Richter L, Grogan TM: Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990, 76:377-382
29. Mathew P, Ahmann GJ, Witzig TE, Roche PC, Kyle RA, Greipp PR: Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity? Br J Haematol 1995, 90:459-461
30. + peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood 1995, 85:436-447
31. Bartl R, Frisch B, Willmanns W: Morphology of multiple myeloma. Myeloma: Biology and Management. Edited by Malpas JS, Bergsagel DE, Kyle RA. New York, Oxford University Press, 1995, pp 82-123
32. Kyle RA: Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 1992, 6:347-358